Expanding HIF Prolyl Hydroxylase Inhibitors to New Therapeutic Applications
Legal Citation
Summary of the Inventive Concept
The present inventive concept explores novel uses of HIF prolyl hydroxylase inhibitors beyond anemia treatment, targeting athletic performance, cognitive function, fatigue reduction, sleep quality, and muscle recovery.
Background and Problem Solved
The original patent focused on treating anemia secondary to chronic kidney disease, chemotherapy, and AIDS. However, the limitations of this patent lie in its narrow scope, neglecting potential applications in other fields. The present inventive concept addresses this limitation by applying HIF prolyl hydroxylase inhibitors to entirely new therapeutic areas.
Detailed Description of the Inventive Concept
The new claims introduce novel uses of HIF prolyl hydroxylase inhibitors in various fields. For instance, Claim 1 proposes a system for monitoring and optimizing athletic performance by administering the inhibitor and measuring hemoglobin levels. Similarly, Claims 2-5 explore the inhibitor's potential in enhancing cognitive function, reducing fatigue, improving sleep quality, and enhancing muscle recovery. These new applications leverage the inhibitor's ability to modulate HIF signaling pathways, unlocking new therapeutic possibilities.
Novelty and Inventive Step
The inventive concept's novelty lies in its unexpected application of HIF prolyl hydroxylase inhibitors to new therapeutic areas, demonstrating an inventive step beyond the original patent's scope. The new claims introduce a paradigm shift in the understanding of the inhibitor's potential, moving beyond anemia treatment to address unmet needs in various fields.
Alternative Embodiments and Variations
Alternative embodiments may include varying the dosage, administration route, or composition of the HIF prolyl hydroxylase inhibitor. Additionally, the inventive concept could be adapted to other diseases or conditions where HIF signaling plays a crucial role, such as cancer, cardiovascular disease, or neurodegenerative disorders.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential, targeting lucrative markets in athletic performance, cognitive function, and chronic disease management. The potential market size is substantial, with opportunities for partnerships, licensing, and product development in various industries.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Pharmaceutical biotechnology, specifically HIF prolyl hydroxylase inhibitor applications in medical treatment and performance enhancement
Person of Ordinary Skill (PHOSITA) Profile
A person with advanced degree in pharmacology or biochemistry, understanding of HIF signaling pathways, experience in drug development, and knowledge of physiological responses to hypoxia-related interventions
Obviousness Rationale
A PHOSITA would recognize that HIF prolyl hydroxylase inhibitors fundamentally modulate oxygen-sensing mechanisms, suggesting potential applications beyond anemia treatment. The source patent establishes the core mechanism of enhancing hemoglobin production, which naturally implies broader physiological performance implications. Given the well-understood signaling pathways, extending the inhibitor's use to performance, cognitive, and recovery domains represents a predictable technological progression.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,543 |
|---|---|
| Title | Compositions and methods for treating anemia |
| Assignee(s) | Akebia Therapeutics, Inc. |